Michael Gelband’s Vaxart VXRT Stock Holding History

Michael Gelband’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-78,439	Closed	-$102K	–	2023
2024 Q1	$102K	Buy	+78,439	New	+$82.2K	﹤0.01%	1412
2023 Q1	–	Sell	-103,363	Closed	-$99K	–	2164
2022 Q4	$99K	Sell	103,363 -315,300	-75%	-$446K	﹤0.01%	1519
2022 Q3	$913K	Buy	418,663 +360,378	+618%	+$1.24M	0.01%	1148
2022 Q2	$204K	Buy	+58,285	New	+$218K	﹤0.01%	1655
2021 Q4	–	Sell	-43,600	Closed	-$347K	–	2637
2021 Q3	$347K	Buy	+43,600	New	+$359K	﹤0.01%	1557
2020 Q4	–	Sell	-25,405	Closed	-$169K	–	2416
2020 Q3	$169K	Buy	+25,405	New	+$226K	﹤0.01%	1518
2020 Q2	–	Sell	-16,100	Closed	-$28K	–	2063
2020 Q1	$28K	Buy	+16,100	New	+$20.5K	﹤0.01%	995

Other funds holding VXRT

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Michael Gelband's VXRT Position: Q2 2024 in Review

Michael Gelband sold out of Vaxart (VXRT) in Q2 2024, closing a stake of 78,439 shares — an estimated $102K sold.

Michael Gelband first reported a position in VXRT in Q1 2020 and held it in 7 quarters. The position peaked at $913K in Q3 2022. 100 funds tracked by Wall St. Rank hold VXRT as of Q2 2024.

Michael Gelband reported no remaining Vaxart position as of Q2 2024 after selling out during the quarter.
Michael Gelband sold 78,439 Vaxart shares in Q2 2024, an estimated $102K.
Michael Gelband first reported a position in Vaxart in Q1 2020 and held it in 7 quarters.
Michael Gelband's Vaxart position peaked at $913K in Q3 2022.
100 funds tracked by Wall St. Rank held Vaxart as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.